Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200)"
 | Up a level |
- Subjects classification (32824)
- Australian and New Zealand Standard Research Classification (32824)
- MEDICAL AND HEALTH SCIENCES (110000) (6766)
- ONCOLOGY AND CARCINOGENESIS (111200) (348)
- MEDICAL AND HEALTH SCIENCES (110000) (6766)
- Australian and New Zealand Standard Research Classification (32824)
Group by: Authors/Creators | Item Type
Number of items at this level: 146.
Book Chapter
Yates, Patsy (2008) Cancer. In Chang, Esther & Johnson, Amanda (Eds.) Chronic Illness and Disability : Principles for Nursing Practice. Churchill Livingstone Elsevier, Chatswood, NSW, pp. 424-437.
Journal Article
Abbas Rizvi, Syed, Song, Emma Yan Jun, Raja, Chand, Beretov, Julia, Morgenstern, Alfred, Apostolidis, Christos, et al. (2008) Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206. Cancer Biology and Therapy, 7(10), pp. 1548-1555.
8
8Aghmesheh, Morteza, Edwards, Lyndal, Clarke, Christine, Byth, Karen, Katzenellenbogen, Benita, Russell, Pamela, et al. (2005) Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas. Gynecologic Oncology, 97(1), pp. 16-25.
2 
2
2 2Anderson, D.J., Yates, P., McCarthy, A.L., Lang, C.P., Hargraves, M., McCarthy, N., et al. (2011) Younger and older women's concerns about menopause after breast cancer. European Journal of Cancer Care, 20(6), pp. 785-794.
1 1
1 1Andrieu, C., Baylot, M., Bladou, Franck, de Thone, Aurelie, Ettinger, Susan, Fazli, Ladan, et al. (2010) Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. Oncogene, 29(13), pp. 1883-1896.
32 29
32 29Baade, P. D., Royle, J., Joske, D, & Fritschi, L. (2011) Risk of second cancer after lymphohematopoietic neoplasm. International Journal of Cancer, 129(4), pp. 910-919.
6 6
6 6Baade, Peter, Dasgupta, Paramita, Aitken, Joanne, & Turrell, Gavin (2011) Geographic remoteness and risk of advanced colorectal cancer at diagnosis in Queensland: a multilevel study. British Journal of Cancer, 105(7), pp. 1039-1041.
2 2
2 2Baade, Peter, Turrell, Gavin, & Aitken, Joanne (2010) A multilevel study of the determinants of area-level inequalities in colorectal cancer survival. BMC Cancer, 10, pp. 1-8.
6 6
6 6Baade, Peter, Youlden, Danny, Valery, Patricia, Hassall, T., Ward, L., Green, Adele, et al. (2010) Trends in incidence of childhood cancer in Australia, 1983-2006. British Journal of Cancer, 102(3), pp. 620-626.
21 18
21 18Baade, Peter D., Carriere, Philippe, & Fritschi, Lin (2008) Trends in testicular germ cell cancer incidence in Australia. Cancer Causes and Control, 19(10), pp. 1043-1049.
11 10
11 10Barnetson, Anthony, Milross, Chris, & Russell, Pamela (2008) An investigation of fludarabine as a potential radiation sensitizer of human prostate cancer cells in vitro. Asia Pacific Journal of Clinical Oncology, 4(1), pp. 48-54.
Batra, Jyotsna, Nagle, Christina, O'Mara, Tracy, Higgins, Melanie, Dong, Ying, Tan, Olivia, et al. (2011) A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival. BMC Cancer, pp. 1-11.
3 3
3 3Batra, Jyotsna, Tan, Olivia, O'Mara, Tracy, Zammit, Rebecca, Nagle, Christina, Clements, Judith, et al. (2010) Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival. International Journal of Gynecological Cancer, 20(4), pp. 529-536.
6 5
6 5Bauskin, Asne, Brown, David, Junankar, Simon, Rasiah, Krishan, Eggleton, Sarah, Hunter, Mark, et al. (2005) The propeptide mediates formation of stromal stores of PROMIC-1: Role in determining prostate cancer outcome. Cancer Research, 65(6), pp. 2330-2336.
48 45
48 45Beadle, Geoffrey, Mengersen, Kerrie, Moynihan, Sean, & Yates, Patsy (2011) Perceptions of the ethical conduct of cancer trials by oncology nurses. European Journal of Cancer Care, 20(5), pp. 585-592.
Beesley, Vanessa L., Janda, Monika, Eakin, Elizabeth G., Obermair, Andreas, & Battistutta, Diana (2007) Lymphedema after gynecological cancer treatment: Prevalence, correlates, and supportive care needs. Cancer, 109(12), pp. 2607-2614.
66 62
66 62Bentley, Rebecca, Kavanagh, Anne Marie, Subramanian, S. V., & Turrell, Gavin (2007) Area disadvantage, individual socio-economic position, and premature cancer mortality in Australia 1998 to 2000 : a multilevel analysis. Cancer Causes & Control, 19(2), pp. 183-193.
16 15
16 15Beraldi, Eliana, Ettinger, Susan, Gleave, Martin, Hadaschik, Boris, Klomp, Leo, Nelson, Colleen, et al. (2010) Clusterin facilitates COMMD1 and I-kB degradation to enhance NF-kB activity in prostate cancer cells. Molecular Cancer Research, 8(1), pp. 119-130.
24 20
24 20Bolderson, Emma, Richard, Derek J., Zhou, Bin-Bing S., & Khanna, Kum Kum (2009) Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clinical Cancer Research, 15(20), pp. 6314-6320.
67 66
67 66Brown, David, Stephan, Carsten, Ward, Robyn, Law, Mathew, Hunter, Mark, Bauskin, Asne, et al. (2006) Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clinical Cancer Research, 12(1), pp. 89-96.
45 41
45 41Buchanan, Grant, Ricciardelli, Carmella, Harris, Jonathan, Prescott, Jennifer, Yu, Chiao, Butler, Lisa, et al. (2007) Control of Androgen Receptor Signaling in Prostate Cancer by the Cochaperone Small Glutamine-rich Tetratricopeptide Repeat Containing Protein Alpha. Cancer Research, 67, pp. 10087-10096.
27 30
27 30Byron, Sara, Gartside, Michael, Wellens, Candice, Goodfellow, Paul, Birrer, Michael, Campbell, Ian, et al. (2010) FGFR2 mutations are rare across histologic subtypes of ovarian cancer. Gynecologic Oncology, 117(1), pp. 125-129.
22 10 8
22 10 8Byron, Sara, Gartside, Michael, Wellens, Candice, Mallon, Mary, Keenan, Jack, Powell, Matthew, et al. (2008) Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation. Cancer Research, 68(17), pp. 6902-6907.
32 44 41
32 44 41Byron, Sara A., Loch, David C., Wellens, Candice L., Wortmann, Andreas, Wu, Jiayi, Wang, John, et al. (2012) Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. BMC Molecular Cancer, 11(75).
25
25Chambers, Suzanner, Baade, Peter, Meng, Xingqiong, Youl, Philippa, Aitken, Joanne, & Dunn, Jeff (2011) Survivor identity after colorectal cancer: Antecedents, prevalence and outcomes. Psycho-Oncology, Online(Online), pp. 1-8.
Chan, Raymond (2010) Cochrane review summary for cancer nursing : drug therapy for cancer-related fatigue. Cancer Nursing, 34(3), pp. 250-251.
17
17Chan, Raymond, Webster, Joan, & Marquart, Louise (2012) A systematic review : the effects of orientation programs for cancer patients and their family/carers. International Journal of Nursing Studies.
26 1
26 1Chan, Raymond Javan (2013) Evidence-based cancer nursing : cancer nursing and the cochrane collaboration. Cancer Nursing, 36(1), pp. 1-2.
Chang, Piek Ngoh, Yap, Wei Ney, Lee, Davy Tak Wing, Ling, Patrick, Wong, Yong Chuan, & Yap, Yee Leng (2009) Evidence of (gamma)-Tocotrienol as an apoptosis-inducing, invasion-suppressing, and chemotherapy drug-sensitizing agent in human melanoma cells. Nutrition and Cancer: an international journal, 61(3), pp. 357-366.
23 21
23 21Cheung, Hiu Wing, Ching, Yick-Pang, Nicholls, John, Ling, Patrick, Wong, Yong Chuan, Hui, Nick, et al. (2005) Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation. Molecular Carcinogenesis, 43(4), pp. 237-245.
31 28
31 28Cheung, Hiu Wing, Chun, Abel, Wang, Qi, Deng, Wen, Hu, Liang, Guan, Xin Yuan, et al. (2006) Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents. Cancer Research, 66(8), pp. 4357-4367.
35 34
35 34Cheung, Hiu Wing, Jin, Dong-Yan, Ling, Patrick, Wong, Yong Chuan, Wang, Qi, Tsao, Sai Wah, et al. (2005) Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Research, 65(4), pp. 1450-1458.
42
42Chu, Qingjun, Ling, Patrick, Feng, Huichen, Cheung, Hiu Wing, Tsao, Sai Wah, Wang, Xiang-Hong, et al. (2006) A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis, 27(11), pp. 2180-2189.
35 31
35 31Chua, Chee Wai, Lee, Tak-Wing, Ling, Patrick, Zhou, Chun, Man, Kwan, Ho, Joanna, et al. (2005) FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer. International Journal of Cancer, 117(6), pp. 1039-1048.
37 35
37 35Demark-Wahnefried, Wendy, Campbell, Kristin, & Hayes, Sandra C. (2012) Weight management and its role in breast cancer rehabilitation. Cancer, 118(S8), pp. 2277-2287.
38 8 6
38 8 6Deryugina, Elena, Conn, Erin, Wortmann, Andreas, Partridge, Juneth, Kupriyanova, Tatyana, Ardi, Veronica, et al. (2009) Functional role of cell surface CUB domain-containing protein 1 in tumour cell dissemination. Molecular Cancer Research, 7(8), pp. 1197-1211.
20 22
20 22Ding, Yi, Wang, Gang, Ling, Patrick, Wong, Yong Chuan, Li, Xin, Na, Yanqun, et al. (2006) Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion. International Journal of Oncology, 28(4), pp. 847-854.
18 18
18 18Doggrell, Sheila (2011) Adherence to oral endocrine treatments in women with breast cancer: can it be improved? Breast Cancer Research and Treatment, 129(2), pp. 299-308.
2 1
2 1Dong, Qihan, Patel, Manish, Scott, Kieran, Graham, Garry, Russell, Pamela, & Sved, Paul (2006) Oncogenic action of phospholipase A2 in prostate cancer. Cancer Letters, 240(1), pp. 9-16.
35 35
35 35Dong, Ying, Tan, Olivia, Loessner, Daniela, Stephens, Carson, Walpole, Carina, Boyle, Glen, et al. (2010) Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha 5 beta1 integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Research, 70(7), pp. 2624-2636.
17 16
17 16Dong, Ying, Walsh, Michael D., Cummings, Margaret C., Wright, R. Gordon, Khoo, Soo Keat, Parsons, Peter G., et al. (1997) Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. The Journal of Pathology, 183(3), pp. 311-317.
76 78
76 78Dong, Ying, Walsh, Michael D., McGuckin, Michael A., Cummings, Margaret C., Gabrielli, Brian G., Wright, Gordon R., et al. (1997) Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer. International Journal of Cancer, 74(4), pp. 407-415.
59 51
59 51Dong, Ying, Walsh, Michael D., McGuckin, Michael A., Gabrielli, Brian B., Cummings, Margaret C., Wright, R. Gordon, et al. (1997) Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis. International Journal of Cancer, 74(1), pp. 57-63.
Eigl, Bernhard, Eggener, Scott, Baybik, Jenny, Ettinger, S, Chi, Kim, Nelson, Colleen, et al. (2005) Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Clinical Cancer Research, 11(13), pp. 4905-4911.
29 27
29 27Fernandez, Tara L., Dawson, Rebecca A., Van Lonkhuyzen, Derek R., Kimlin, Michael G., & Upton, Zee (2012) A tan in a test tube -in vitro models for investigating ultraviolet radiation-induced damage in skin. Experimental Dermatology, 21(6), pp. 404-410.
Finnane, Anna, Hayes, Sandra C., Obermair, Andreas, & Janda, Monika (2011) Quality of life of women with lower-limb lymphedema following gynecological cancer. Expert Review of Pharmacoeconomics and Outcomes Research, 11(3), pp. 287-297.
53 3 3
53 3 3Finnane, Anna, Liu, Yuan, Battistutta, Diana, Janda, Monika, & Hayes, Sandra C. (2011) Lymphedema after breast or gynecological cancer : use and effectiveness of mainstream and complementary therapies. Journal of Alternative and Complementary Medicine, 17(9), pp. 867-869.
66 3 2
66 3 2Fleshner, Neil, Haddad, Ahmed, Klotz, Laurence, Musquera, Mireia, Nelson, Colleen, Saour, Basil, et al. (2010) Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cells. Nutrition and Cancer: an international journal, 62(5), pp. 668-681.
4 3
4 3Fung, M.K.L., Cheung, Hiu Wing, Ling, Patrick, Cheung, A.L.M., Wong, Yong Chuan, & Wang, Xiang-Hong (2006) Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells. British Journal of Cancer, 95(4), pp. 475-484.
12 13
12 13Gao, Kai, Karst, Alison, Li, Gang, & Nelson, Colleen (2009) Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. International Journal of Cancer, 124(2), pp. 494-501.
15 14
15 14Gao, Ling-Juan, Gu, Ping-Qing, Fan, Wei-Min, Liu, Zhu, Qiu, Feng, Peng, Yu-Zhu, et al. (2011) The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells. International Journal of Oncology, 39(5), pp. 1265-1272.
2 2
2 2Gartside, Michael, Chen, Huaibin, Ibrahimi, Omar, Byron, Sara, Curtis, Amy, Wellens, Candice, et al. (2009) Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research, 7(1), pp. 41-54.
19 29 26
19 29 26Gordon, Louisa S., Lynch, Brigid M., & Newman, Beth M. (2008) Transitions in work participation after a diagnosis of colorectal cancer. Australian and New Zealand Journal of Public Health, 32(6), pp. 569-574.
6 4
6 4Hao, J., Chen, H., Madigan, Michele, Cozzi, Paul, Beretov, Julia, Xiao, W., et al. (2010) Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. British Journal of Cancer, 103(7), pp. 1008-1018.
18 14
18 14Hausdorf, Katrin, Eakin, Elizabeth G., Whiteman, David C., Rogers, Carla M., Aitken, Joanne F., & Newman, Beth M. (2008) Prevalence and correlates of multiple cancer risk behaviors in an Australian population-based survey : results from the Queensland Cancer Risk Study. Cancer Causes and Control, 19(10), pp. 1339-1347.
6 8
6 8Hawkes, Anna L., Hamilton, Kyra, White, Katherine M., & Young, Ross (2012) A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade') : study protocol. BMC Cancer, 12(1), p. 1.
24
24Hawkes, Anna L., Pakenham, Kenneth I., Courneya, Kerry, Gollschewski, Sara E., Baade, Peter D., Gordon, Louisa S., et al. (2009) A randomised controlled trial of a tele-based lifestyle intervention for colorectal cancer survivors ('CanChange') : Study protocol. B M C Cancer, 9(286), pp. 1-8.
15 10 9
15 10 9Hayes, Sandi, Speck, Rebecca, Reimet, Elizabeth, Stark, Azadeh, & Schmitz, Kathryn (2011) Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial. Breast Cancer Research and Treatment, 130(1), pp. 227-234.
3 3
3 3Hayes, Sandra C., Janda, Monika, Cornish , Bruce, & Newman , Beth (2009) Correspondence : lymphedema following breast cancer. Journal of Clinical Oncology, 27(17), p. 1.
1 1
1 1Hayes, Sandra C., Johansson, Karin, Stout, Nicole L., Prosnitz, Robert G., Armer, Jane M., Gabram, Sheryl, et al. (2012) Upper-body morbidity after breast cancer : incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer, 118(S8), pp. 2237-2249.
1 7 8
1 7 8Hayes, Sandra C., Rye, Sheree, Battistutta, Diana, DiSipio, Tracey, & Newman, Beth (2010) Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health and Quality of Life Outcomes, 8(92).
34 18 18
34 18 18Howard, Edward, Ling, Patrick, Chua, Chee Wai, Cheung, Hiu Wing, Wang, Xiang-Hong, & Wong, Yong Chuan (2007) Garlic-derived S-allylmercaptocysteine Is a novel In vivo antimetastatic agent for androgen-independent prostate cancer. Clinical Cancer Research, 13(6), pp. 1847-1856.
28 28
28 28Hughes, Karen, Sargeant, Hilary, & Hawkes, Anna (2011) Acceptability of the distress thermometer and problem list to community-based telephone cancer helpline operators, and to cancer patients and carers. BMC Cancer, pp. 1-8.
4 4
4 4Hui, Cheuk Man, Cheung, Pak Yan, Ling, Patrick, Tsao, Sai Wah, Wang, Xiang-Hong, Wong, Yong Chuan, et al. (2006) Id-1 promotes proliferation of p53-deficient esophageal cancer cells. International Journal of Cancer, 119(3), pp. 508-514.
25 22
25 22Hung, Tzong-Tyng, Wang, Hong, Kingsley, Elizabeth, Risbridger, Gail, & Russell, Pamela (2008) Molecular profiling of bladder cancer: Involvement of the TGF-ß pathway in bladder cancer progression. Cancer Letters, 265(1), pp. 27-38.
9 10
9 10Huynh, Hung, Ngo, Van Chanh, Fargnoli, Joseph, Ayers, Mark, Soo, Khee Chee, Nung, Koong Heng, et al. (2008) Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Clinical Cancer Research, 14(19), pp. 6146-6153.
88 85
88 85Isenring, Elisabeth A., Cross, Giordana, Kellett , Elizabeth, Koczwara, Bogda, & Daniels, Lynne A. (2010) Nutritional status and information needs of medical oncology patients receiving treatment at an Australian public hospital. Nutrition and Cancer, 62(2), pp. 220-228.
299 6 3
299 6 3Janda, Monika, Youl, Philippa H., Lowe, John B., Baade, Peter D., Elwood, Mark, Ring, Ian T., et al. (2006) What motivates men age ≥ 50 years to participate in a screening program for melanoma? Cancer, 107(4), pp. 815-823.
157 21 20
157 21 20Jekimovs, C.R., Chen, X., Arnold, J., Gatei, M., Richard, D.J., Spurdle, A.B., et al. (2005) Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families : functional analysis in heterozygous individuals. British Journal of Cancer, 92(4), pp. 784-790.
20 20
20 20Kricker, Anne, DiSipio, Tracey, Stone, Jennifer, Goumas, Chris, Armes, Jane E, Gertig, Dorota M., et al. (2011) Bodyweight and other correlates of symptom detected breast cancers in a population offered screening. Cancer Causes & Control, 23, pp. 89-102.
6 1 1
6 1 1Krnjacki, Lauren J., Baade, Peter D., Lynch, Brigid M., & Aitken, Joanne F. (2008) Reliability of collecting colorectal cancer stage information from pathology reports and general practitioners in Queensland. Australian and New Zealand Journal of Public Health, 32(4), p. 378.
5 6
5 6Kwok, Wai Kei, Ling, Patrick, Lee, Tak-Wing, Lau, Tracy, Zhou, Chun, Zhang, Xiao-Meng, et al. (2005) Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Research, 65(12), pp. 5153-5162.
198 180
198 180Kwok, Wai Kei, Ling, Patrick, Yuen, Hiu Fung, Wong, Yong Chuan, & Wang, Xiang-Hong (2007) Role of p14ARF in TWIST-mediated senescence in prostate epithelial cells. Carcinogenesis, 28(12), pp. 2467-2475.
19 19
19 19Laky, Brenda, Janda, Monika, Kondalsamy-Chennakesavan, Srinivas, Cleghorn, Geoffrey, & Obermair, Andreas (2010) Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: A cohort study. BMC Cancer, 10(1), pp. 232-237.
55 11 9
55 11 9Lee, Terence, Poon, Ronnie, Yuen, Anthony, Ling, Patrick, Kwok, Wai Kei, Wang, Xiang-Hong, et al. (2006) Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research, 12(18), pp. 5369-5376.
143 125
143 125Lee, Terence, Poon, Ronnie, Yuen, Anthony, Ling, Patrick, Wang, Xiang-Hong, Wong, Yong Chuan, et al. (2006) Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Clinical Cancer Research, 12(23), pp. 6910-6919.
28 24
28 24Lee, Yen-Ching, Perren, Janeanne, Douglas, Evelyn, Raynor, Michael, Bartley, Maria, Bardy, Peter, et al. (2005) Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma. BMC Cancer, 5, p. 119.
17 12
17 12Li, Bin, Cheung, Pak Yan, Wang, Xiang-Hong, Tsao, Sai Wah, Ling, Patrick, Wong, Yong Chuan, et al. (2007) Id-1 activation of PI3K/Akt/NF(kappa)B signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis, 28(11), pp. 2313-2320.
39 39
39 39Ling, Patrick, Kwok, Wai Kei, Fung, Maggie, Wang, Xiang-Hong, & Wong, Yong Chuan (2006) Proteasome mediated degradation of Id-1 is associated with TNF (alpha) -induced apoptosis in prostate cancer cells. Carcinogenesis, 27(2), pp. 205-215.
8 7
8 7Ling, Patrick, Lau, Tracy, Zhou, Chun, Chua, Chee Wai, Kwok, Wai Kei, Wang, Qi, et al. (2005) Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis, 26(10), pp. 1668-1676.
64 62
64 62Lloyd, Julia, McIver, Cassandra, Stephenson, Sally-Anne, Hewett, Peter, Rieger, Nicholas, & Hardingham, Jennifer (2006) Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clinical Cancer Research, 12(2), pp. 417-423.
38 36
38 36Loch, David & Pollock, Pamela M. (2012) Lineage-specific biomarkers predict response to FGFR inhibition. Cancer Discovery, 2, pp. 1081-1083.
Locke, Jennifer, Guns, Emma, Lubik, Amy, Adomat, Hans, Hendy, Stephen, Wood, Catherine, et al. (2008) Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer. Cancer Research, 68(15), pp. 6407-6415.
208 191
208 191Loessner, D., Quent, V.M.C., Kraemer , J., Weber, E., Hutmacher, D.W., Magdolen, Viktor, et al. (2012) Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance. Gynecologic Oncology, 127(3), pp. 569-578.
9
9Lose, Felicity, Batra, Jyotsna, O'Mara, Tracy, Fahey, Paul, Marquart, Louise, Eeles, Rosalind, et al. (2011) Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. Urologic Oncology: Seminars and Original Investigations, Online(Online), pp. 1-9.
Lose, Felicity, Nagle, Christina, O'Mara, Tracy, Batra, Jyotsna, Bolton, Kelly, Song, Honglin, et al. (2010) Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival. Gynecologic Oncology, 119(3), pp. 479-483.
11 8
11 8Lose, Felicity, Srinivasan, Srilakshmi, O'Mara, Tracy, Marquart, Louise, Chambers, Suzanne, Gardiner, Robert, et al. (2012) Genetic association of the KLK4 locus with risk of prostate cancer. PLoS ONE, 7(9), e44520.
37
37Lubik, Amy, Gunter, Jennifer, Hendy, Stephen, Locke, Jennifer, Adomat, Hans, Thompson, Vanessa, et al. (2011) Insulin increases de novo steroidogenesis in prostate cancer cells. Cancer Research, 71(17), pp. 5754-5764.
22 14
22 14Luk, Sze Ue, Yap, Wei Ney, Chiu, Yung-Tuen, Lee, Davy T.W., Ma, Stephanie, Lee, Terence Kin Wah, et al. (2010) Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. International Journal of Cancer.
17 11
17 11Lynch, Brigid M., Youlden, Danny R., Fritschi, Lin, Newman, Beth M., Pakenham, Kenneth I., Leggett, Barbara, et al. (2008) Self-reported information on the diagnosis of colorectal cancer was reliable but not necessarily valid. Journal of Clinical Epidemiology, 61(5), pp. 498-504.
11 9
11 9Ma, Stephanie, Chan, Yuen Piu, Kwan, Pak Shing, Lee, Terence, Yan, Mingxia, Tang, Kwan Ho, et al. (2011) MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. Cancer Research, 71(2), pp. 583-592.
6 6
6 6Ma, Stephanie, Chan, Yuen Piu, Woolcock, Bruce, Hu, Liang, Wong, Kai Yau, Ling, Patrick, et al. (2009) DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancer. International Journal of Cancer, 124(10), pp. 2323-2332.
4 4
4 4Margiotti, Katia, Wafa, Latif, Cheng, Helen, Novelli, Giuseppe, Nelson, Colleen, & Rennie, Paul (2007) Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells. Molecular Cancer, 6(38), pp. 1-11.
15 14
15 14McCaul, Kieran, Fritschi, Lin, Baade, Peter, & Coory, Michael (2008) The incidence of second primary invasive melanoma in Queensland, 1982-2003. Cancer Causes & Control: an international journal of studies of cancer in human populations, 19(5), pp. 451-458.
13 12
13 12Millikan, Robert C., Newman, Beth M., Tse, Chiu-Kit, Moorman, Patricia G., Conway, Kathleen, Smith, Lisa V., et al. (2008) Epidemiology of basal-like breast cancer. Breast Cancer Research and Treatment, 109(1), pp. 123-139.
202 181
202 181Morris, Bronwyn A. & Shakespeare-Finch, Jane (2010) Rumination, post-traumatic growth, and distress : structural equation modelling with cancer survivors. Psycho-Oncology. (In Press)
236 5 2
236 5 2Mostaghel, Elahe, Page, Stephanie, Lin, Daniel, Fazli, Ladan, Coleman, Ilsa, True, Lawrence, et al. (2007) Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer. Cancer Research, 67(10), pp. 5033-5041.
184 171
184 171Packer, Leisl, Pavey, Sandra, Parker, Andrew, Stark, Mitchell, Johansson, Peter, Clarke, Belinda, et al. (2006) Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN. Carcinogenesis: integrative cancer research, 27(9), pp. 1778-1786.
30 26
30 26Passier, Leanne, Doherty, Dominique, Smith, Jayne, & McPhail, Steven (2012) Vestibular rehabilitation following the removal of an acoustic neuroma : a systematic review of randomized trials. Head and Neck Oncology, 4(2), p. 59.
Patel, Manish, Singh, Jas, Niknami, Marzieh, Kurek, Caroline, Yao, Mu, Lu, Sasa, et al. (2008) Cytosolic phospholipase A2-a: A potential therapeutic target for prostate cancer. Clinical Cancer Research, 14(24), pp. 8070-8079.
21 19
21 19Pinnix, Chelsea, Lee, John, Liu, Zhao-Jun, McDaid, Ronan, Balint, Klara, Beverly, Levi, et al. (2009) Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Research, 69(13), pp. 5312-5320.
5 34 31
5 34 31Pollock, P.M., Yu, F., Qiu, L., Parsons, P.G., & Hayward, N.K. (1995) Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene, 11(4), pp. 663-668.
98
98Pollock, Pamela M., Stark, Mitchell S., Palmer, Jane M., Walters, Marilyn K., Aitken, Joanne F., Martin, N. G., et al. (2001) Mutation analysis of the CDKN2A promoter in Australian melanoma families. Genes Chromosomes Cancer, 32(1), pp. 89-94.
16 15
16 15Qin, Jian-Zhong, Ziffra, Jeffrey, Stennett, Lawrence, Bodner, Barbara, Bonish, Brian, Chaturvedi, Vijaya, et al. (2005) Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. Cancer Research, 65(14), pp. 6282-6293.
151 145
151 145Ralph, Jody, Orgebin-Crist, Marie, Lareyre, Jean, & Nelson, Colleen (2003) Disruption of androgen regulation in the prostate by the environmental contaminant hexachlorobenzene. Environmental Health Perspectives, 111(4), pp. 461-466.
7 28 23
7 28 23Raynor, Michael, Stephenson, Sally-Anne, Pittman, Kenneth, Walsh, David, Henderson, Michael, & Dobrovic, Alexander (2009) Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR. Journal of Hematology and Oncology, 9(424), pp. 1-11.
12 10
12 10Roberts, Aedan, Nancarrow, Derek, Clendenning, Mark, Buchanan, Daniel, Jenkins, Mark, Duggan, David, et al. (2010) Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome). Familial Cancer, 10(2), pp. 245-254.
2 3
2 3Rocchi, Palma, Beraldi, Eliana, Ettinger, Susan, Fazli, Ladan, Vessella, Robert, Nelson, Colleen, et al. (2005) Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Cancer Research, 65(23), pp. 11083-11093.
89 90
89 90Royle, Jill, Baade, Peter, Joske, David, Girschik, Jen, & Fritschi, Lin (2011) Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. British Journal of Cancer, 105(7), pp. 1076-1081.
12 9
12 9Shiota, Masaki, Zoubeidi, Amina, Kumano, Masafumi, Beraldi, Eliana, Naito, Seiji, Nelson, Colleen, et al. (2011) Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer. Molecular Cancer Research, 9(12), pp. 1755-1766.
8 3
8 3Singh, Preetinder, Joshi, Swapna, Russell, Pamela, Nair, Sham, & Khatri, Aparajita (2011) Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: A tangible union against chemoresistant cancer. BMC Cancer, pp. 1-15.
2 2
2 2Singh, Preetinder Pal, Joshi, Swapna, Russell, Pamela, Verma, Nirupama, Wang, Xiaochun, & Khatri, Aparajita (2011) Molecular chemotherapy and chemotherapy: A new front against late-stage hormone-refractory prostate cancer. Clinical Cancer Research, 17(12), pp. 4006-4018.
3 2
3 2Skalicky, Simon, Ow, Kim, Hannan, M., Russell, Pamela, & Yang, Jia-Lin (2007) p53 expression is associated with malignant potential in xenograft tissues of a fibrosarcoma mouse model. Anticancer Research: international journal of cancer research and treatment, 27(2), pp. 973-978.
3 2
3 2Snoek, Robert, Cheng, Helen, Margiotti, Katia, Wafa, Latif, Wong, Charmaine, Chan Wong, Erica, et al. (2009) In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumours. Clinical Cancer Research, 15(1), pp. 39-47.
46 39
46 39Spence, Rosalind, Heesch, Kristiann, Eakin, Elizabeth, & Brown, Wendy (2007) Randomised controlled trial of a supervised exercise rehabilitation program for colorectal cancer survivors immediately after chemotherapy: study protocol. BMC Cancer, 7, pp. 1-11.
5 7
5 7Stephenson, Sally-Anne, Stephens, Camilla M., Maclean, Donald J., & Manners, John M. (2005) CgDN24 : a gene involved in hyphal development in the fungal phytopathogen Colletotrichum gloeosporioides. Microbiological Research, 160(4), pp. 389-397.
1 1
1 1Thompson, Ella, Dragovic, Rebecca, Stephenson, Sally-Anne, Eccles, Diana, Campbell, Ian, & Dobrovic, Alexander (2005) A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer. BMC Cancer, 5(43), pp. 1-6.
12 10
12 10Thompson, Vanessa, Day, Tanya, Bianco-Miotto, Tina, Selth, Luke, Han, Guangzhou, Thomas, Mervyn, et al. (2011) A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. International Journal of Cancer, Online(Online), pp. 1-11.
Traka, Maria, Chambers, Karen F., Lund, Elizabeth, Goodlad, Robert, Johnson, Ian, & Mithen, Richard (2009) Involvement of KLF4 in sulforaphane- and iberin-mediated induction of p21waf1/cip1. Nutrition and Cancer, 61(1), pp. 137-145.
10 10
10 10Tramm, Ralph, McCarthy, Alexandra L., & Yates, Patsy (2011) Dietary modification for women after breast cancer treatment : a narrative review. European Journal Of Cancer Care, 20(3), pp. 294-304.
39 2 1
39 2 1Turner, Jane, Kelly, Brian, Clarke, David, Yates, Patsy, Aranda, Sanchia, Jolley, Damien, et al. (2011) A randomised trial of a psychosocial intervention for cancer patients integrated into routine care: The PROMPT study (promoting optimal outcomes in mood through tailored psychosocial therapies). BMC Cancer, pp. 1-9.
5 3
5 3Vandyke, Kate, Jackson, Paul, Rowe, Alexandra, Russell, Pamela, & Blair, Julie (2007) Androgen decreases osteoprotegerin expression in prostate cancer cells. Prostate Cancer and Prostatic Diseases, 10(2), pp. 160-166.
Wallace,, Harris, Jonathan, & Subramaniam, Nathan (2009) Functional analysis and theoretical modelling of ferroportin reveals clustering of mutations according to phenotype. Cancer Research, 298(1), pp. 75-84.
16 15
16 15Walsh, M.D., Buchanan, D.D., Cummings, M.C., Pearson, S.A., Arnold, S.T., Clendenning, M., et al. (2010) Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clinical Cancer Research, 16(7), pp. 2214-2224.
9 24 21
9 24 21Wang, Qian, Bailey, Charles, Ng, Cynthia, Tiffen, Jessamy, Thoeng, Annora, Minhas, Vineet, et al. (2011) Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. Cancer Research, 71(24), pp. 7525-7536.
7 5
7 5Ward, Leigh, Winall, Ann, Isenring, Elisabeth, Hills, Andrew, Czerniec, Sharon, Dylke, Elizabeth, et al. (2011) Assessment of bilateral limb lymphedema by bioelectrical impedance spectroscopy. International Journal of Gynecological Cancer, 21(2), pp. 409-418.
5 4
5 4White, Benjamin P., Willmott, Lindy, & Ashby, Michael (2011) Palliative care, double effect and the law in Australia. Internal Medicine Journal, 41(6), pp. 485-492.
144 1 1
144 1 1Xu, K., Ling, Patrick, Wang, Xiang-Hong, & Wong, Yong Chuan (2006) Evidence of a novel biomarker, alphas1-Casein, a milk protein, in benign prostate hyperplasia. Prostate Cancer and Prostatic Diseases, 9(3), pp. 293-297.
3 3
3 3Yang, Jia-Lin, Hannan, M., Russell, Pamela, & Crowe, Philip (2006) Expression of HER1/EGFR protein in human soft tissue sarcomas. European Journal of Surgical Oncology, 32(4), pp. 466-468.
8 10
8 10Yang, Jia-Lin, Qu, Xian-Jun, Russell, Pamela, & Goldstein, David (2005) Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines. Cancer Letters, 225(1), pp. 61-74.
5 5
5 5Yang, Jia-Lin, Qu, Xian-Jun, Russell, Pamela, & Goldstein, David (2005) Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines. Oncology: international journal of cancer research and treatment, 69(3), pp. 224-238.
10 9
10 9Yap, W., Chang, P.N., Han, Hui-Ying, Lee, D.T.W., Ling, Patrick, Wong, Yong Chuan, et al. (2008) Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways. British Journal of Cancer, 99(11), pp. 1832-1841.
42 38
42 38Yap, Wei Ney, Zaiden, Norazean, Tan, Yee Ling, Ngoh, Chang Piek, Zhang, Xue Wu, Wong, Y.C., et al. (2010) Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells. Cancer Letters, 291(2), pp. 187-199.
14 12
14 12You, Jingjing, Madigan, Michele, Rowe, Alexandra, Sajinovic, Mila, Russell, Pamela, & Jackson, Paul (2010) An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines. Urologic Oncology: Seminars and Original Investigations, Online(Online), pp. 1-7.
Youl, P. H., Janda, M., Aitken, J. F., Del Mar, C. B., Whiteman, D. C., & Baade, P. D. (2011) Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice. British Journal Of Dermatology. (In Press)
4 5
4 5Youl, Philippa, Baade, Peter, Aitken, Joanne, Chambers, Suzanne, Turrell, Gavin, Pyke, Chris, et al. (2011) A multilevel investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer. BMC Cancer, pp. 1-8.
1 1
1 1Youlden, Danny & Baade, Peter (2011) The relative risk of second primary cancers in Queensland, Australia: A retrospective cohort study. BMC Cancer, 11(83), pp. 1-12.
6 6
6 6Yu, D, Scott, C, JIA, W, De Benedetti, A, Williams, B, Fazli, Ladan, et al. (2006) Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter. Cancer Gene Therapy, 13(1), pp. 32-43.
20 17
20 17Zhang, An Ling & Russell, Pamela (2006) Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice. Cancer Letters, 233(1), pp. 185-191.
7 5
7 5Zhang, Xiao-Meng, Ling, Patrick, Wang, Xiang-Hong, & Wong, Yong Chuan (2006) Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. International Journal of Cancer, 118(8), pp. 2072-2081.
31 27
31 27Zhang, Xiao-Meng, Ling, Patrick, Wong, Yong Chuan, & Wang, Xiang-Hong (2007) Evidence of a novel antiapoptotic factor: Role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis. Cancer Science, 98(3), pp. 308-314.
19 18
19 18Zhang, Xiao-Meng, Wang, Qi, Ling, Patrick, Wong, Yong Chuan, Leung, Steve, & Wang, Xiang-Hong (2007) Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. International Journal of Cancer, 120(9), pp. 1891-1898.
38 33
38 33Zhou, Chun, Ling, Patrick, Lee, Terence, Man, Kwan, Wang, Xiang-Hong, & Wong, Yong Chuan (2006) FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase. Cancer Letters, 233(1), pp. 36-47.
24 23
24 23Zoubeidi, Amina, Zardan, Anousheh, Beraldi, Eliana, Fazli, Ladan, Sowery, Richard, Rennie, Paul, et al. (2007) Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Cancer Research, 67(21), pp. 10455-10465.
66 68
66 68Conference Paper
Eakin, Elizabeth G., Lawler, Sheleigh P., Spathonis, Kym, Harrison, Sheree, Winkler, Elisabeth, Newman, Beth M., et al. (2009) Preliminary Results from Exercise for Health : A Breast Cancer Recovery Project [Abstract]. In Proceedings of the 15th International Breast Cancer Support Conference : Reach to Recovery, Brisbane Convention and Exhibition Centre, Brisbane.
31
31Milne, Jillian, Battistutta, Diana, Newman, Beth M., & Hayes, Sandi (2009) Longitudinal patterns of weight in women diagnosed with breast cancer [Conference Abstract]. In Asia Pacific Journal of Clinical Oncology [Special Issue: Abstracts of the 36th Annual Scientific Meeting, Clinical Oncological Society of Australia], Wiley-Blackwell Publishing Ltd., Gold Coast Convention Centre, Gold Coast, Queensland, A236-A237.
13
13